Picture of ChemoMetec A/S logo

CHEMM ChemoMetec A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Chemometec Hikes FY 2024/25 Revenue, EBITDA Guidance

Dec 3 (Reuters) - Chemometec A/S  CHEMM.CO :
    * REPORTS BETTER-THAN-EXPECTED SALES AND ORDER INTAKE IN Q2
2024/25
    * NOW EXPECTS REVENUE FOR 2024/25 FINANCIAL YEAR IN DKK
460-475
MILLION RANGE
    * SEES 2024/25 EBITDA IN DKK 230-240 MILLION RANGE
    * PREVIOUS FY REVENUE GUIDANCE DKK 445-460 MILLION
    * PREVIOUS FY EBITDA GUIDANCE DKK 222-230 MILLION

Source text:  ID:nGNE4sNqgd 
Further company coverage:  CHEMM.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on ChemoMetec A/S

See all news